| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.05 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |